P | | a || g || e
| | | ||1
NAGELHOUT PHARMACOLOGY 2 EXAM NEW
UPDATE 2026 EXAM QUESTIONS AND 100%
VERIFIED SOLUTIONS
What does mixing LAs do to your toxic doses? - CORRECT-ANSWER-
|| || || || || || || || || ||
decreases them; the toxicity is additive so if you have used 50% of
|| || || || || || || || || || || || ||
your lidocaine dose and watch to switch to bupivacaine- you can
|| || || || || || || || || || ||
only give 50% of your toxic bupivacaine dose
|| || || || || || || ||
How is the spread of epidural and spinal anesthesia different in
|| || || || || || || || || ||
pregnant women? - CORRECT-ANSWER-the spread and depth is
|| || || || || || || ||
greater; the fetus is pushing back so you have decreased epidural
|| || || || || || || || || || ||
space
||
How does pregnancy change the dosage of LA given? -
|| || || || || || || || ||
CORRECT- ANSWER-give decreased dose; they are more
|| || || || || || ||
sensitive to LA d/t increased hormone (progesterone) levels
|| || || || || || || ||
, P | | a || g || e
| | | ||2
Lidocaine for tumescent anesthesia - CORRECT-ANSWER-they use
|| || || || || ||
large amounts of diluted LA for liposuction; doses from 35-55mg/kg
|| || || || || || || || || ||
(if not lipo 28mg/kg)
|| || || ||
What is Hyaluronidase - CORRECT-ANSWER-an enzyme that helps
|| || || || || || ||
break down tissue matrix; breaks down hyaluronic acid so fluids can
|| || || || || || || || || || ||
go further;
|| ||
*helps spread LA* || ||
this also increases the risk of toxicity
|| || || || || ||
Receptor type: relaxation of gallbladder and ducts - CORRECT-
|| || || || || || || ||
ANSWER-
beta 2 ||
Receptor type: contraction of gall bladder and ducts -
|| || || || || || || ||
CORRECT- ANSWER-M
|| ||
, P | | a || g || e
| | | ||3
Receptor type: increased renin secretion - CORRECT-ANSWER-B1
|| || || || || ||
Receptor type: relaxation of the detrusor of bladder -
|| || || || || || || ||
CORRECT- ANSWER-B2
|| ||
Receptor type: contraction of detrusor (bladder) - CORRECT-ANSWER-
|| || || || || || ||
M
Receptor type: contraction of trigone and bladder sphincter -
|| || || || || || || ||
CORRECT- ANSWER-alpha 1
|| || ||
Receptor type: relaxation of trigone and sphincter - CORRECT-
|| || || || || || || ||
ANSWER-
M
Receptor type: contraction of pregnant uterus - CORRECT-ANSWER-
|| || || || || || ||
alpha 1
||
, P | | a || g || e
| | | ||4
Receptor type: relaxation of uterus in pregnant and nonpregnant -
|| || || || || || || || ||
CORRECT-ANSWER-beta 2 ||
Receptor type: glycogenolysis and gluconeogenesis in liver -
|| || || || || || ||
CORRECT- ANSWER-alpha 1
|| || ||
Receptor type: increased blood sugar - CORRECT-ANSWER-beta 2
|| || || || || || ||
Receptor type: decreased insulin secretion from beta cells in the
|| || || || || || || || ||
pancrease - CORRECT-ANSWER-alpha 2
|| || || ||
Receptor type: increased insulin secretion from beta cells in pancreas -
|| || || || || || || || || ||
CORRECT-ANSWER-beta 2 ||
| | | ||1
NAGELHOUT PHARMACOLOGY 2 EXAM NEW
UPDATE 2026 EXAM QUESTIONS AND 100%
VERIFIED SOLUTIONS
What does mixing LAs do to your toxic doses? - CORRECT-ANSWER-
|| || || || || || || || || ||
decreases them; the toxicity is additive so if you have used 50% of
|| || || || || || || || || || || || ||
your lidocaine dose and watch to switch to bupivacaine- you can
|| || || || || || || || || || ||
only give 50% of your toxic bupivacaine dose
|| || || || || || || ||
How is the spread of epidural and spinal anesthesia different in
|| || || || || || || || || ||
pregnant women? - CORRECT-ANSWER-the spread and depth is
|| || || || || || || ||
greater; the fetus is pushing back so you have decreased epidural
|| || || || || || || || || || ||
space
||
How does pregnancy change the dosage of LA given? -
|| || || || || || || || ||
CORRECT- ANSWER-give decreased dose; they are more
|| || || || || || ||
sensitive to LA d/t increased hormone (progesterone) levels
|| || || || || || || ||
, P | | a || g || e
| | | ||2
Lidocaine for tumescent anesthesia - CORRECT-ANSWER-they use
|| || || || || ||
large amounts of diluted LA for liposuction; doses from 35-55mg/kg
|| || || || || || || || || ||
(if not lipo 28mg/kg)
|| || || ||
What is Hyaluronidase - CORRECT-ANSWER-an enzyme that helps
|| || || || || || ||
break down tissue matrix; breaks down hyaluronic acid so fluids can
|| || || || || || || || || || ||
go further;
|| ||
*helps spread LA* || ||
this also increases the risk of toxicity
|| || || || || ||
Receptor type: relaxation of gallbladder and ducts - CORRECT-
|| || || || || || || ||
ANSWER-
beta 2 ||
Receptor type: contraction of gall bladder and ducts -
|| || || || || || || ||
CORRECT- ANSWER-M
|| ||
, P | | a || g || e
| | | ||3
Receptor type: increased renin secretion - CORRECT-ANSWER-B1
|| || || || || ||
Receptor type: relaxation of the detrusor of bladder -
|| || || || || || || ||
CORRECT- ANSWER-B2
|| ||
Receptor type: contraction of detrusor (bladder) - CORRECT-ANSWER-
|| || || || || || ||
M
Receptor type: contraction of trigone and bladder sphincter -
|| || || || || || || ||
CORRECT- ANSWER-alpha 1
|| || ||
Receptor type: relaxation of trigone and sphincter - CORRECT-
|| || || || || || || ||
ANSWER-
M
Receptor type: contraction of pregnant uterus - CORRECT-ANSWER-
|| || || || || || ||
alpha 1
||
, P | | a || g || e
| | | ||4
Receptor type: relaxation of uterus in pregnant and nonpregnant -
|| || || || || || || || ||
CORRECT-ANSWER-beta 2 ||
Receptor type: glycogenolysis and gluconeogenesis in liver -
|| || || || || || ||
CORRECT- ANSWER-alpha 1
|| || ||
Receptor type: increased blood sugar - CORRECT-ANSWER-beta 2
|| || || || || || ||
Receptor type: decreased insulin secretion from beta cells in the
|| || || || || || || || ||
pancrease - CORRECT-ANSWER-alpha 2
|| || || ||
Receptor type: increased insulin secretion from beta cells in pancreas -
|| || || || || || || || || ||
CORRECT-ANSWER-beta 2 ||
